The HROC-Xenobank-A High Quality Assured PDX Biobank of >100 Individual Colorectal Cancer Models.
CRC
PDX model
histological examination
mutation analysis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
23 Nov 2021
23 Nov 2021
Historique:
received:
28
10
2021
revised:
18
11
2021
accepted:
19
11
2021
entrez:
10
12
2021
pubmed:
11
12
2021
medline:
11
12
2021
Statut:
epublish
Résumé
Based on our research group's large biobank of colorectal cancers (CRC), we here describe the ongoing activity of establishing a high quality assured PDX biobank for more than 100 individual CRC cases. This includes sufficient numbers of vitally frozen (
Identifiants
pubmed: 34884989
pii: cancers13235882
doi: 10.3390/cancers13235882
pmc: PMC8656526
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : State Mecklenburg-Vorpommern
ID : TBI-V-1-241-VBW-084
Références
Anticancer Res. 2021 May;41(5):2257-2275
pubmed: 33952452
Lab Invest. 2020 Jan;100(1):27-37
pubmed: 31409886
Transl Oncol. 2021 Aug;14(8):101133
pubmed: 34051622
World J Gastroenterol. 2015 Jan 7;21(1):164-76
pubmed: 25574089
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Cancer Res. 2019 Nov 15;79(22):5884-5896
pubmed: 31585941
Cancer Res. 2007 Jan 1;67(1):398-407
pubmed: 17210723
Br J Cancer. 2021 Apr;124(8):1411-1420
pubmed: 33558709
Int J Oncol. 2009 Aug;35(2):321-7
pubmed: 19578746
Cells. 2019 Jan 20;8(1):
pubmed: 30669516
Clin Cancer Res. 2019 Oct 15;25(20):6243-6259
pubmed: 31375513
Oncotarget. 2016 Oct 4;7(40):66212-66225
pubmed: 27517155
BMC Med Res Methodol. 2019 Jul 8;19(1):142
pubmed: 31286896
Nat Genet. 2021 Jan;53(1):86-99
pubmed: 33414553
J Hematol Oncol. 2020 Jan 7;13(1):4
pubmed: 31910904
Mol Oncol. 2021 Dec;15(12):3404-3429
pubmed: 34258881
Br J Cancer. 1978 Feb;37(2):213-23
pubmed: 629859
Front Microbiol. 2018 Apr 24;9:789
pubmed: 29755432
Vet Pathol. 2020 Jan;57(1):160-171
pubmed: 31736441
Cancer Discov. 2014 Sep;4(9):998-1013
pubmed: 25185190
Am J Cancer Res. 2014 Nov 19;4(6):824-37
pubmed: 25520871
Oncotarget. 2015 Jun 30;6(18):16059-68
pubmed: 25965827
J Exp Clin Cancer Res. 2021 Jun 1;40(1):178
pubmed: 34074330
PLoS One. 2017 Oct 17;12(10):e0186271
pubmed: 29040282
Sci Rep. 2021 Apr 14;11(1):8154
pubmed: 33854094
Nat Commun. 2015 Apr 30;6:7002
pubmed: 25926053
Nat Rev Clin Oncol. 2012 Apr 17;9(6):338-50
pubmed: 22508028
J Vis Exp. 2021 Apr 10;(170):
pubmed: 33900297
Bioinformatics. 2011 Aug 1;27(15):2156-8
pubmed: 21653522
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Sci Rep. 2020 Feb 17;10(1):2778
pubmed: 32066753
Langenbecks Arch Surg. 2013 Feb;398(2):251-8
pubmed: 23292500
Nat Methods. 2018 Aug;15(8):591-594
pubmed: 30013048
Cancer Res. 2017 Nov 1;77(21):e62-e66
pubmed: 29092942
BMC Genet. 2016 Apr 21;17:62
pubmed: 27098093
Cancers (Basel). 2019 Oct 09;11(10):
pubmed: 31601052
Neoplasia. 2015 Sep;17(9):735-741
pubmed: 26476081
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Semin Cancer Biol. 2019 Apr;55:37-52
pubmed: 29775690
Front Oncol. 2018 Feb 19;8:19
pubmed: 29515970
Gut. 2006 Jul;55(7):1000-6
pubmed: 16407376
Nat Genet. 2006 Jul;38(7):787-93
pubmed: 16804544
Cancers (Basel). 2019 Sep 06;11(9):
pubmed: 31500168
EMBO J. 2019 Aug 1;38(15):e101654
pubmed: 31282586
BMC Cancer. 2010 Jul 08;10:362
pubmed: 20615215
Cancers (Basel). 2020 Aug 19;12(9):
pubmed: 32825052